Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Real-world clinical outcomes of treatment with molnupiravir for patients with mild-to-moderate coronavirus disease 2019 during the Omicron variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Iizuka T, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Waragai Y, Kambe T, Kanzaki N, Azuma T, Okamoto H, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Abe W, Tsukada Y, Lee T, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Hamaguchi S, Iseki K

Clinical and experimental medicine   23 ( 6 )   2715 - 2723   2023.10（ ISSN:1591-8890 ）

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.

Shibata Y, Omae K, Minemura H, Suzuki Y, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kambe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Inage M, Hirama N, Furuyama K, Fukushima S, Saito H, Machiya JI, Machida H, Abe K, Iwabuchi K, Katagiri Y, Aida Y, Abe Y, Ota T, Ishizawa Y, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Kurita N, Iseki K

BMC pulmonary medicine   23 ( 1 )   312   2023.8

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Effect of Colchicine on Recurrent Serositis in Familial Mediterranean Fever.

Suzuki Y, Saito J, Fukuhara A, Rikimaru M, Morimoto J, Lee T, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Togawa R, Sato Y, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Shibata Y

The American journal of medicine   136 ( 6 )   e117 - e118   2023.6（ ISSN:0002-9343 ）

Usefulness of diurnal variation of fractional exhaled nitric oxide for predicting early therapeutic response to asthma treatment.

Uematsu M, Saito J, Sato S, Fukuhara A, Suzuki Y, Rikimaru M, Onuma T, Tomita H, Watanabe N, Saito M, Morimoto J, Kawamata T, Umeda T, Togawa R, Sato Y, Koizumi T, Hirai K, Minemura H, Nikaido T, Kanazawa K, Tanino Y, Munakata M, Shibata Y

The Journal of asthma : official journal of the Association for the Care of Asthma   59 ( 10 )   2039 - 2050   2022.10（ ISSN:0277-0903 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Imai H, Nagai Y, Minemura H, Tsuda T, Yamada Y, Wasamoto S, Kishikawa T, Shiono A, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Minato K, Kagamu H

Investigational new drugs   40 ( 5 )   1066 - 1079   2022.10（ ISSN:0167-6997 ）

Post-progression survival after atezolizumab plus carboplatin and etoposide as first-line chemotherapy in small cell lung cancer has a significant impact on overall survival.

Masubuchi K, Imai H, Wasamoto S, Tsuda T, Minemura H, Nagai Y, Yamada Y, Kishikawa T, Umeda Y, Shiono A, Takechi H, Shiihara J, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Kagamu H, Minato K

Thoracic cancer   13 ( 19 )   2776 - 2785   2022.10（ ISSN:1759-7706 ）

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

A normal pattern of mitral inflow predicts a better prognosis following cardiovascular events in early advanced-age patients.

Watanabe T, Iwai-Takano M, Saitoh H, Kanazawa K, Igarashi T, Fujimiya T, Ohira T

Scientific reports   12 ( 1 )   9594   2022.6

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Watanabe N, Sato R, Yamada R, Onuma T, Tomita H, Saito M, Rikimaru M, Morimoto J, Suzuki Y, Minemura H, Saito J, Kanazawa K, Yamada S, Hashimoto Y, Shibata Y

BMC pulmonary medicine   22 ( 1 )   191   2022.5

Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic.

Suzuki Y, Shibata Y, Minemura H, Nikaido T, Tanino Y, Fukuhara A, Kanno R, Saito H, Suzuki S, Ishii T, Inokoshi Y, Sando E, Sakuma H, Kobayashi T, Kume H, Kamimoto M, Aoki H, Takama A, Kamiyama T, Nakayama M, Saito K, Tanigawa K, Sato M, Kanbe T, Kanzaki N, Azuma T, Sakamoto K, Nakamura Y, Ohtani H, Waragai M, Maeda S, Ishida T, Sugino K, Tsukada Y, Yamada R, Sato R, Onuma T, Tomita H, Saito M, Watanabe N, Rikimaru M, Kawamata T, Umeda T, Morimoto J, Togawa R, Sato Y, Saito J, Kanazawa K, Iseki K

International journal of medical sciences   19 ( 5 )   834 - 841   2022（ ISSN:14491907 ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.

Kotake M, Imai H, Kaira K, Endoh H, Yamada Y, Kaburagi T, Kiyoshima M, Sugiyama T, Nakamura Y, Kasai T, Matsuguma H, Minemura H, Kanazawa K, Suzuki H, Fujita A, Minato K

Chemotherapy   67 ( 3 )   142 - 151   2022（ ISSN:0009-3157 ）

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer.

Wasamoto S, Imai H, Tsuda T, Nagai Y, Minemura H, Yamada Y, Umeda Y, Kishikawa T, Shiono A, Kozu Y, Shiihara J, Yamaguchi O, Mouri A, Kaira K, Kanazawa K, Taniguchi H, Kaburagi T, Minato K, Kagamu H

Frontiers in oncology   12   1080729   2022（ ISSN:2234-943X ）

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Cancer medicine   10 ( 20 )   6971 - 6984   2021.10

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

Outpatient Cardiac Rehabilitation Suppresses Deterioration of Renal Function in Patients ≥75 Years of Age With Heart Disease.

Sasamoto Y, Endo N, Kanazawa K, Utsumi T, Takahashi T, Endo Y, Nanba M, Takeda H, Takano T, Takahashi K, Tanji M, Kohzuki M

Circulation journal : official journal of the Japanese Circulation Society   85 ( 5 )   612 - 622   2021.4（ ISSN:1346-9843 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験　North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302.

Kawashima Y, Harada T, Fujita Y, Nakagawa T, Watanabe K, Morikawa N, Takamura K, Kanazawa K, Kuda T, Usui K, Sekine A, Inoue A, Sugawara S

International journal of clinical oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

化学療法未施行の扁平上皮癌に対するカルボプラチン+ナブパクリタキセルとシスプラチン+ゲムシタビンの無作為化第II相試験 North Japan lung cancer study group 1302(Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naieve squamous cell carcinoma: North Japan lung cancer study group 1302)

Kawashima Yosuke, Harada Toshiyuki, Fujita Yuka, Nakagawa Taku, Watanabe Kana, Morikawa Naoto, Takamura Kei, Kanazawa Kenya, Kuda Tomoya, Usui Kazuhiro, Sekine Akimasa, Inoue Akira, Sugawara Shunichi

International Journal of Clinical Oncology   26 ( 3 )   515 - 522   2021.3（ ISSN:1341-9625 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Association Between Sleep Characteristics and Asthma Control in Middle-Aged and Older Adults: A Prospective Cohort Study.

Sato S, Saito J, Fukuhara A, Uematsu M, Suzuki Y, Rikimaru M, Kawamata T, Umeda T, Koizumi T, Togawa R, Sato Y, Nikaido T, Minemura H, Kanazawa K, Tanino Y, Shibata Y

Journal of asthma and allergy   14   325 - 334   2021（ ISSN:1178-6965 ）

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.

Imai H, Kishikawa T, Minemura H, Yamada Y, Ibe T, Mori K, Yamaguchi O, Mouri A, Hamamoto Y, Kanazawa K, Kasai T, Kaira K, Kaburagi T, Minato K, Kobayashi K, Kagamu H

Oncology   99 ( 9 )   562 - 570   2021（ ISSN:0030-2414 ）

Prognostic value of morphological characteristics assessed by CT scan in patients with non-small cell lung cancer treated with nivolumab.

Minemura H, Moriya H, Imai H, Sugiyama T, Yamada Y, Higuchi M, Kaira K, Ozaki Y, Kanazawa K, Yokouchi H, Kasai T, Kaburagi T, Suzuki H, Minato K, Shibata Y

Thoracic cancer   11 ( 12 )   3521 - 3527   2020.12（ ISSN:1759-7706 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study.

Suzuki Y, Minemura H, Tomita H, Saito M, Watanabe N, Umeda T, Kawamata T, Rikimaru M, Morimoto J, Koizumi T, Togawa R, Sato Y, Hirai K, Uematsu M, Nikaido T, Fukuhara N, Fukuhara A, Sato S, Saito J, Kanazawa K, Tanino Y, Shibata Y

Internal medicine (Tokyo, Japan)   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫　稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

汎下垂体機能低下症を伴い自然軽快したサルコイドーシスの1例

河俣 貴也, 谷野 功典, 二階堂 雄文, 佐藤 佑樹, 東川 隆一, 鈴木 康仁, 渡邉 菜摘, 齋藤 美加子, 力丸 真美, 梅田 隆志, 小泉 達彦, 平井 健一郎, 植松 学, 峯村 浩之, 福原 敦朗, 佐藤 俊, 斎藤 純平, 金沢 賢也, 蛇沢 晶, 柴田 陽光

日本サルコイドーシス/肉芽腫性疾患学会雑誌   40 ( 1-2 )   29 - 34   2020.10（ ISSN:1883-1273 ）

Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.

Imai H, Minemura H, Kishikawa T, Yamada Y, Suzuki K, Umeda Y, Wasamoto S, Kasahara N, Ishihara S, Yamaguchi O, Naruse I, Uchino J, Mori K, Kanazawa K, Shibata Y, Kasai T, Kaburagi T, Kaira K, Minato K

Thoracic cancer   11 ( 10 )   2867 - 2876   2020.10（ ISSN:1759-7706 ）

肺・脳に浸潤する単形性上皮向性腸管T細胞リンパ腫 稀な1症例の研究(Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Involving the Lung and Brain: A Rare Case Study)

Suzuki Yasuhito, Minemura Hiroyuki, Tomita Hikaru, Saito Mikako, Watanabe Natsumi, Umeda Takashi, Kawamata Takaya, Rikimaru Mami, Morimoto Julia, Koizumi Tatsuhiko, Togawa Ryuichi, Sato Yuki, Hirai Kenichiro, Uematsu Manabu, Nikaido Takefumi, Fukuhara Naoko, Fukuhara Atsuro, Sato Suguru, Saito Junpei, Kanazawa Kenya, Tanino Yoshinori, Shibata Yoko

Internal Medicine   59 ( 20 )   2559 - 2563   2020.10（ ISSN:0918-2918 ）

Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.

Yamaguchi O, Imai H, Minemura H, Suzuki K, Wasamoto S, Umeda Y, Osaki T, Kasahara N, Uchino J, Sugiyama T, Ishihara S, Ishii H, Naruse I, Mori K, Kotake M, Kanazawa K, Minato K, Kagamu H, Kaira K

Cancer chemotherapy and pharmacology   85 ( 4 )   761 - 771   2020.4（ ISSN:0344-5704 ）

Clinical significance of thyroid hormone and antibodies in patients with idiopathic interstitial pneumonia.

Sato Y, Tanino Y, Nikaido T, Togawa R, Kawamata T, Wang X, Fukuhara N, Tomita H, Saito M, Watanabe N, Rikimaru M, Umeda T, Morimoto J, Koizumi T, Suzuki Y, Hirai K, Uematsu M, Minemura H, Fukuhara A, Sato S, Saito J, Kanazawa K, Shibata Y

Journal of thoracic disease   12 ( 3 )   522 - 537   2020.3（ ISSN:2072-1439 ）

Gill-Shorr染色変法を用いたEBUS-TBNAにおける迅速細胞診(ROSE)の有用性の検討

峯村 浩之, 金沢 賢也, 平井 健一郎, 小泉 達彦, 梅田 隆志, 佐藤 佑樹, 横内 浩, 谷野 功典, 棟方 充, 柴田 陽光

気管支学   42 ( 2 )   123 - 128   2020.3（ ISSN:0287-2137 ）